Cyclins and Autoimmunity: Cyclin B1 Gene Expression and Restriction Fragment Length Polymorphism in Lupus-Prone Mice

References

• Murray A. W. Creative blocks: Cell-cycle checkpoints and feedback controls. Nature (Lond.) 1992; 359: 599–604
   PubMed Web of Science ®Google Scholar
• Hunter T. Braking the cycle. Cell 1993; 75: 839–841
   PubMed Web of Science ®Google Scholar
• Hunter T., Pines J. Cyclins and cancer II: Cyclin D and cyclin dependent kinase inhibitors come of age. Cell 1994; 79: 573–582
   PubMed Web of Science ®Google Scholar
• Koff A., Cross F., Fishe A., Schumacher J., Leguellec K., Philippe M., Roberts J. M. Human cyclin E., a new cyclin that interacts with two members of the CDC2 gene family. Cell 1991; 66: 1217–1228
   PubMed Web of Science ®Google Scholar
• Ajchenbaum F., Ando K., Decaprio A., Griffin J. D. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 1993; 268: 4113–4119
   PubMed Web of Science ®Google Scholar
• Sheer C. J. Mammalian G1 cyclins. Cell 1993; 73: 1059–1065
   PubMed Web of Science ®Google Scholar
• Pines J., Hunter T. Human cyclin A is adenovirus E1A-associated protein p60, and behaves differently from cyclin B. Nature (Lond.) 1990; 346: 760–763
   PubMed Web of Science ®Google Scholar
• Nasmyth K. A. Far-reaching discoveries about the regulation of START. Cell 1990; 63: 1117–1120
   PubMed Web of Science ®Google Scholar
• Nurse P. Universal control mechanisms regulating onset of M-phase. Nature (Lond.) 1990; 344: 503–508
   PubMed Web of Science ®Google Scholar
• Murray A. W., Solomon M. J., Kirschner M. W. The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature (Lond.) 1991; 349: 132–138
   PubMedGoogle Scholar
• Galaktionov K., Beach D. Specific activation of cdc25 tyrosine phosphatase by B-type cyclins: Evidence for multiple roles of mitotic cyclins. Cell 1991; 67: 1181–1194
   PubMed Web of Science ®Google Scholar
• Westedorf J. M., Swenson K. I., Ruderman J. V. The role of cyclin B1 in meiosis. J. Cell. Biol. 1989; 108: 1431–1444
   PubMed Web of Science ®Google Scholar
• Gong J., Ardelt B., Traganos F., Darzynkiewicz Z. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res. 1994; 54: 4285–4288
   PubMed Web of Science ®Google Scholar
• Thomas T., Thomas T. J. Regulation of cyclin B1 by estradiol and polyamines in MCF 7 breast cancer cells. Cancer Res. 1994; 54: 1077–1084
   PubMed Web of Science ®Google Scholar
• Glotzer M., Murray A. W., Kirschner M. W. Cyclin is degraded by the ubiquitin pathway. Nature (Lond.) 1991; 349: 132–138
   PubMed Web of Science ®Google Scholar
• Chapman D. L., Wolgemuth D. J. Identification of a mouse B-type cyclin which exhibits developmentally regulated expression in germ line. Mol. Rep. Dev. 1992; 33: 259–269
   PubMed Web of Science ®Google Scholar
• Chapman D. L., Wolgemuth D. J. Isolation of murine cyclin B2 cDNA and characterization of the lineage and temporal specificity of expression of the B1 and B2 cyclins during oogenesis, spermatogenesis and early embryogenesis. Development 1993; 118: 229–240
   PubMed Web of Science ®Google Scholar
• Firpo E. J., Koff A., Solomon M. J., Roberts J. M. Inactivation of cdk2 during interleukin-2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 1994; 14: 4889–4901
   PubMed Web of Science ®Google Scholar
• Kim Y. H., Proust J. J., Buchholz M. J., Chrest F. J., Nordin A. A. Expression of the murine homologue of the cell cycle control protein p34cdc2 in T lymphocytes. J. Immunol. 1992; 149: 17–23
   PubMed Web of Science ®Google Scholar
• Roy-Walker P., Kwast-Welfeld J., Gourdeau H., Leblanc J., Neugebauer W., Sirkoska M. Relationship between apoptosis and the cell cycle in lymphocytes: Roles of protein kinase C., tyrosine phosphorylation, and AP-1. Exp. Cell. Res. 1993; 207: 142–151
   PubMed Web of Science ®Google Scholar
• Boehme S. A., Lenardo M. J. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 1993; 23: 1532–1534
   Web of Science ®Google Scholar
• Zhu L., Anasetti C. Cell cycle control of apoptosis in human leukemic T cells. J. Immunol. 1995; 154: 192–200
   PubMed Web of Science ®Google Scholar
• Pisetsky D. S. Systemic lupus erythematosus. Curr. Opin. Immunol. 1991; 3: 917–923
   PubMed Web of Science ®Google Scholar
• Tan E. M., Chan E. K. Molecular biology of autoantigens and new insights into autoimmunity. Clin. Invest. 1993; 71: 327–330
   PubMedGoogle Scholar
• Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndrome: Clinical and immunopathological manifestations in several strains. J. Exp. Med. 1978; 148: 1198–1207
   PubMed Web of Science ®Google Scholar
• Steinberg A. D., Raveche E., Laskin C. A., Smith H. A., Santoro T., Miller M. L., Plotz P. H. Systemic lupus erythematosus: Insights from animal models. Ann. Internal. Med. 1984; 100: 714–727
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R., Brannan C. I., Copeland N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.) 1992; 356: 314–317
   PubMed Web of Science ®Google Scholar
• Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S.-I., Sameshima M., Hase A., Seto Y. and Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
   PubMed Web of Science ®Google Scholar
• Nagata S., Suda T. Fas and Fas ligand: Ipr and gld mutations. Immunol. Today 1995; 16: 39–43
   PubMedGoogle Scholar
• Giese T., Davidson W. F. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. 1 Immunol. 1992; 149: 3097–4009
   PubMed Web of Science ®Google Scholar
• Merino R., Iwamoto M., Fossati L., Izui S. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB × NZW)F1 and MRL/MpJ-/pr//pr mice. J. Immunol. 1993; 151: 6509–6516
   PubMed Web of Science ®Google Scholar
• Raveche E. S., Steinberg A. D., DeFranco A. L., Tjio J.-T. Cell cycle analysis of lymphocyte activation in normal and autoimmune strains of mice. J. Immunol. 1982; 129: 1219–1226
   PubMed Web of Science ®Google Scholar
• Steinberg A. D., Roths J. B., Murphy E. T., Steinberg R. T., Raveche E. S. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL-lpr/lpr mice. J. Immunol. 1982; 125: 871–873
   Web of Science ®Google Scholar
• Zhou T., Bluethmann H., Eldridge J., Berry K., Mountz J. D. Origin of CD4−CD8−B220+ T cells in MRL-lpr/lpr mice. J. Immunol. 1993; 150: 3651–3667
   PubMed Web of Science ®Google Scholar
• Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Bio Techniques 1993; 15: 532–537
   PubMed Web of Science ®Google Scholar
• Gross-Bellard M., Oudet P., Chambon P. Isolation of high molecular-weight DNA from mammalian cells. Eur. J. Biochem. 1973; 36: 32–38
   PubMedGoogle Scholar
• Dean P. N. Techniques in Cell Cycle Research: Data analysis in cell kinetics, J. W. Gray, Z. Darzynkiewicz. Human Press, Clifton, NJ 1987; 207–253
   Google Scholar
• Hanley-Hyde J., Frederic M., Sodofsky M., Huppi K., Krall M., Kozak C. A., Mock B. Expression of murine cyclin B1 mRNAs and genetic mapping of related genomic sequences. Genomics 1992; 13: 1018–1030
   PubMed Web of Science ®Google Scholar
• Lock L. F., Pines J., Hunter T., Gilbert D. J., Gopalan G., Jenkins N. A., Copeland N. G., Donovan P. J. A single cyclin A gene and multiple cyclin B1-related sequences are dispersed in the mouse genome. Genomics 1992; 13: 415–424
   PubMed Web of Science ®Google Scholar
• Maity A., McKenna W. G., Muschel R. J. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J. 1995; 14: 603–609
   PubMed Web of Science ®Google Scholar
• Thomas T. J., Gunnia U. B., Thomas T. Genetic variations of polyamine biosynthesis in autoimmune mice. Arthritis Rheum. 1990; 33: S80, (Abstract)
   PubMedGoogle Scholar
• Thomas T. J., Gunnia U. B., Thomas T. Reversal of the abnormal development of T cell subpopulation in the thymus of autoimmune MRL-lpr/lpr mice by a polyamine biosynthesis inhibitor. Autoimmunity 1992; 13: 275–283
   PubMed Web of Science ®Google Scholar
• Itoh N., Tsujimoto Y., Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 1993; 151: 621–627
   PubMed Web of Science ®Google Scholar
• Smith M. J., Trapani J. A. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 1995; 16: 202–206
   PubMedGoogle Scholar
• Meikrantz W., Gisselbrecht S., Tarn S., Schlegel R. Activation of cyclin A dependent protein kinase during apoptosis. Proc. Natl Acad. Sci. USA 1994; 91: 3754–3758
   PubMed Web of Science ®Google Scholar
• Brunner T., Mogil R. J., LaFance D., Yoo N. J., Mahboubi A., Echeverri F., Martin S. J., Force W. R., Lynch D. H., Ware C. F., Green D. R. Cell-autonomous Fas (CD95)/Fas ligand interaction mediates activation-induced apoptosis in T-Cell hybridomas. Nature (Lond.) 1995; 373: 441–444
   PubMed Web of Science ®Google Scholar
• Smith K. A. Interleukin-2; Inception, impact, and implication. Science 1986; 230: 1169–1176
   Google Scholar
• Stern J. B., Smith K. A. Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science 1986; 233: 203–206
   PubMed Web of Science ®Google Scholar
• Altman A., Theofilopoulos A. N., Weiner R., Katz D. H., Dixon F. J. Analysis of T cell function in autoimmune murine strains: defects in production and responsiveness to interleukin 2. J. Exp. Med. 1981; 154: 791–808
   PubMed Web of Science ®Google Scholar
• Wofsy D., Murphy E. D., Roths J. B., Dauphinee M. J., Kipper S. B., Talal N. Deficient interleukin-2 activity in MRL/MpJ and C57BL/6J mice bearing the lpr gene. J. Exp. Med. 1981; 154: 1671–1680
   PubMed Web of Science ®Google Scholar
• Mountz J. D., Steinberg A. D., Klinman D. M., Smith H. R., Mushinski J. F. Autoimmunity and increased c-myb transcription. Science 1984; 226: 1087–1090
   PubMed Web of Science ®Google Scholar
• Mountz J. D., Steinberg A. D. Studies of c-myb gene regulation in MRL-lpr/lpr mice-Identification of a 5 ' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells. J. Immunol. 1989; 142: 328–335
   PubMed Web of Science ®Google Scholar
• Izui S., Kelley V. E., Masuda K., Yoshida H., Roth J. B., Murphy E. D. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 1984; 133: 227–233
   PubMed Web of Science ®Google Scholar
• Kakkaniah V. N., Pyle R. H., Nagarkatti M., Nagarkatti P. S. Evidence for a major alterations in the thymocyte subpopulations in murine models of autoimmune disease. J. Autoimmunity 1990; 3: 271–288
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A. N., Kofler R., Singer P. A., Dixon F. J. Molecular genetics of murine lupus models. Adv. Immunol. 1989; 46: 61–109
   PubMed Web of Science ®Google Scholar
• Tsao Y. P., D'Arpa P., Liu L. F. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B1. Cancer Res. 1992; 52: 1823–1829
   PubMed Web of Science ®Google Scholar